Structure (Spironolactone 01)
Spironolactone Tablet, Film Coated
Product Images NDC 63629-1066
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
Figure 2 (Spironolactone 03)
This is a table depicting the results of a study evaluating the effectiveness of Spironolactone compared to Placebo in managing subgroup patients with Diabetes and creatinine levels. The table presents the results indicating the levels of Subgroup, Heart Faure, Diabetes, Creatinine, Pomatts sam, Potassium, and Beta Blocker. It also presents a chart with horizontal axis depicting time (in months) and vertical axis depicting effectiveness of the treatment, with Spironolactone performing better than Placebo.*
Spironolactone 50mg (Spironolactone 05)
This is a description of Spironolactone Tablets, USP. Each tablet contains 50mg of Spironolactone, which is an ingredient in medicine used for fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver, and nephrotic syndrome. The medication should be kept away from children and stored at a temperature between 20°C to 25°C. It should also be dispensed in a tight container with a child-resistant closure. The text includes additional information like a product code, manufacturer details, and some illegible characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
